See also this year's filing and all EDGAR filings for this company.
PDF Report 0000828878_2014_HH_Biotechnology_Holdings_CO.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 1.852386642736301e-08, 'aggregate_val': 53984409, 'exp_sum': 53984410, 'exp_to_value': {'RealEstateInvestments': 0, 'IntangibleAssets': 0, 'remainder_Assets': 53984410}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000828878')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000828878, HH Biotechnology Holdings CO
| xvar | xval | |
|---|---|---|
| 0 | RealEstateInvestmentPropertyAtCost | 0 |
| 1 | RealEstateInvestmentPropertyAccumulatedDepreciation | 0 |
| 2 | remainder_RealEstateInvestments | 0 |
| 3 | LiabilitiesLongTerm | 0 |
| 4 | LiabilitiesCurrent | 35,543,124 |
| 5 | remainder_Liabilities | 0 |
| 6 | IntangibleAssets | 0 |
| 7 | remainder_Assets | 59,555,164 |
| 8 | LeaseIncome | 5,579,651 |
| 9 | remainder_Revenues | 0 |
| 10 | CostOfRevenue | 5,046,524 |
| 11 | DepreciationAndAmortization | 18,590 |
| 12 | GeneralAndAdministrativeExpense | 1,828,869 |
| 13 | remainder_Expenses | 1,457,417 |
| 14 | remainder_NetIncome | 957,351 |
| 15 | remainder_ComprehensiveNetIncome | 706,781 |
| yvar | yval | |
|---|---|---|
| 0 | RealEstateInvestments | 0 |
| 1 | Liabilities | 35,543,124 |
| 2 | Assets | 59,555,164 |
| 3 | Revenues | 5,579,651 |
| 4 | Expenses | 8,351,400 |
| 5 | StockholdersEquity | 24,012,040 |
| 6 | NetIncome | -1,814,398 |
| 7 | ComprehensiveNetIncome | -1,411,533 |
| 8 | BaseVar | 57,841,965 |
| 9 | EconomicCapitalRatiobeforeLimitedLiability | 0.294 |
| 10 | EconomicCapitalRatio | 0.576 |
Edgar->Model Mapping
Feature Distribution
